E4Z

Baloxavir acid


Toggle HydrogenToggle Labels

Chemical Component Summary

NameBaloxavir acid
Identifiers(3~{R})-2-[(11~{S})-7,8-bis(fluoranyl)-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-oxidanyl-5-oxa-1,2,8-triazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-diene-9,12-dione
FormulaC24 H19 F2 N3 O4 S
Molecular Weight483.487
TypeNON-POLYMER
Isomeric SMILESc1ccc2c(c1)[C@H](c3ccc(c(c3CS2)F)F)N4[C@@H]5COCCN5C(=O)C6=C(C(=O)C=CN64)O
InChIInChI=1S/C24H19F2N3O4S/c25-16-6-5-13-15(20(16)26)12-34-18-4-2-1-3-14(18)21(13)29-19-11-33-10-9-27(19)24(32)22-23(31)17(30)7-8-28(22)29/h1-8,19,21,31H,9-12H2/t19-,21+/m1/s1
InChIKeyFIDLLEYNNRGVFR-CTNGQTDRSA-N

Chemical Details

Formal Charge0
Atom Count53
Chiral Atom Count2
Bond Count58
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB15675 
NameBaloxavir
Groups investigational
DescriptionBaloxavir is under investigation in clinical trial NCT04327791 (Combination Therapy With Baloxavir and Oseltamavir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1)).
SynonymsBaloxavir
Categories
  • Anti-Infective Agents
  • Antiviral Agents
  • Baloxavir and prodrugs
  • Chelating Activity
  • Enzyme Inhibitors
CAS number1985605-59-1

Related Resource References

Resource NameReference
PubChem 124081876
ChEMBL CHEMBL4297215